title: [Wellness-activities to prevent metabolic syndrome among patients with schizophrenia].
abstract: OBJECTIVE
  Weight gain and metabolic disturbances are growing side effects of a modern antipsychotic therapy. Different programs were developed to reduce them. This article gives an overview of existing and evaluated programs.
  
  
  METHODS
  A literature research was made through PubMed. Relevant reviews and intervention studies were identified.
  
  
  RESULTS
  Studies with the main outcome variable of weight reductions are numerous, even randomised controlled trials. Short-term weight loss under antipsychotic treatment is possible, but there is still a lack of long-term studies. Life style interventions, which include e. g. physical exercise, are not that common. Also, interventions such as wellness-activities, which contribute by means of adequate motivation strategies to an enhancement of the general well-being, are still missing. Present results turned out to be positive.
  
  
  CONCLUSIONS
  Further programs which exceed weight management are required. There is necessity for more studies with consistent outcome variables and methods, especially long-term programs.
authors: Klinik und Poliklinik für Psychiatrie und Psychotherapie des Klinikums rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675 München. m.broenner@mnet-online.de
authors: Monika
authors: M
authors: Brönner
authors: Christine
authors: C
authors: Betz
authors: Sarah
authors: S
authors: Christ
authors: Teresa
authors: T
authors: Froböse
authors: Gabi
authors: G
authors: Pitschel-Walz
authors: Josef
authors: J
authors: Bäuml
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D003131:Combined Modality Therapy; D004038:Diet, Reducing / Q000523:psychology; D015444:Exercise; D015438:Health Behavior; D006801:Humans; D008019:Life Style; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000517:prevention & control*; D009042:Motivation; D010349:Patient Compliance / Q000523:psychology; D010353:Patient Education as Topic; D011788:Quality of Life / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D015431:Weight Loss
chemical_list: D014150:Antipsychotic Agents